GGrantIndex
Sort

172,184 grants matching inflammation

Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease

$3,067,743
Melissa Erin Murray · Mayo Clinic Jacksonville · R01 · FY2022 · AG

Role of the Cell Death Machinery in a Somatic Autoinflammatory Syndrome

$3,066,524
Alexander Gitlin · Sloan-Kettering Inst Can Research · R01 · FY2025 · AI

Engineered metabolite-based nanoparticles for immunomodulation of macrophages to treat obesity

$3,065,252
Alireza Hassani Najafabadi · Terasaki Institute For Biomedical Innovation · R01 · FY2025 · DK

Case Clinical Trials Unit

$3,065,181
Michael Marcel Lederman · Case Western Reserve University · UM1 · FY2014 · AI

Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab

$3,063,266
Joren C Madsen · Massachusetts General Hospital · U01 · FY2022 · AI

Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations

$3,062,013
Hillard S Kaplan · Chapman University · R01 · FY2024 · AG

Immunometabolic phenotypes in adult severe asthma and disease progression

$3,058,207
Bruce D Levy · Brigham And Women'S Hospital · U01 · FY2021 · HL

Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity

$3,057,531
Ignacio E. Sanz · Emory University · U54 · FY2023 · CA

Prenatal Exposures and Child Health Outcomes: A Statewide Study

$3,057,227
Nigel S Paneth · Michigan State University · UH3 · FY2018 · OD

Biology of the Prostate Cancer Prevention Trial (PCPT)

$3,057,118
Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2006 · CA

Cell Signaling of Host Defense

$3,056,873
Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES

RNA modifications in apolipoprotein regulation by environmental exposures

$3,051,769
Carolyn M. Klinge · University Of Louisville · R01 · FY2025 · ES

Role of the Non-canonical Inflammasome in SARS-CoV-2-mediated Pathology and Coagulopathy

$3,046,145
Amal O Amer · Ohio State University · P01 · FY2024 · AI

Laboratory of Molecular Imaging and Nanomedicine

$3,046,083
Xiaoyuan Chen · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2014 · EB

The intersection of immunity and cardiovascular diseases

$3,043,800
David G Harrison · Vanderbilt University Medical Center · P01 · FY2025 · HL

Complications of Hemolysis and Transfusion Therapy

$3,043,095
Karina Yazdanbakhsh · New York Blood Center · P01 · FY2025 · HL

MECHANISMS AND TREATMENT OF COPD PROGRESSION

$3,041,763
Robert A. Wise · Johns Hopkins University · P50 · FY2009 · HL

Complications of Hemolysis and Transfusion Therapy

$3,041,589
Karina Yazdanbakhsh · New York Blood Center · P01 · FY2024 · HL

Controlling and preventing Asthma progression and Severity in Kids (CASK)

$3,041,164
Wanda Phipatanakul · Boston Children'S Hospital · U01 · FY2021 · AI

The Natural History of Cognitive Decline in Chronic Kidney Disease: Renal, Vascular and Alzheimer's Disease Contributions

$3,037,165
Anne M Murray · Hennepin Healthcare Research Institute · RF1 · FY2018 · AG

COVID-19: immune response and systems vaccinology

$3,036,975
Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Amyloid and inflammation: modulation by apoE, gender, air pollution, and drugs

$3,035,654
Caleb E Finch · University Of Southern California · RF1 · FY2015 · AG

Women HIV Cohort Study: HIV infection and treatment among women of reproductive age

$3,035,518
Maria Luisa Alcaide · University Of Miami School Of Medicine · R01 · FY2020 · HD

MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS

$3,033,308
Neelum T Aggarwal · Rush University Medical Center · R01 · FY2024 · AG

Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab

$3,029,663
Joren C Madsen · Massachusetts General Hospital · U01 · FY2018 · AI